NewswireToday - /newswire/ -
Redwood Shores, CA, United States, 2013/06/24 - Enhanced cloud offering builds on success of oracle Argus safety 7.0, now includes oracle Argus Japan, oracle Argus analytics and oracle Argus insight (NASDAQ: ORCL) - Oracle.com. NYSE, NASDAQ: ORCL
To help health sciences organizations meet increasingly stringent regulatory requirements and ensure product safety while optimizing IT return on investment, Oracle Health Sciences has expanded its Oracle Argus Cloud Service to enable global monitoring and deliver new insight into adverse events and pharmacovigilance programs.
The cloud-based version of Oracle’s leading integrated global adverse events management and regulatory reporting suite now includes Oracle Argus Japan. This addition creates a single global database for safety data, including data from Japan, and enables a unified workflow and reporting environment designed to improve process efficiency and expand visibility.
Oracle Argus Cloud Service also includes expanded analytical and reporting capabilities that help to integrate safety and risk management.
Oracle Argus Analytics provides study sponsors and clinical research organizations with fact-based insight into safety data collection and case processing to help boost productivity and reduce costs. Completely integrated with Argus Safety, the solution features flexible, pre-built dashboards that enable users to quickly drill down into case details. Organizations also can quickly create new reports using pre-defined measures.
Oracle Argus Insight enables study sponsors and medical reviewers to carefully analyze pharmaceutical safety data and make business decisions quickly and confidently. The new addition to Oracle Argus Cloud Service allows users to create queries and reports from millions of cases in minutes, extracting information from an organization’s safety data mart for analysis and reporting without impeding daily use of mission-critical drug safety databases.
Oracle Argus Cloud Service, delivered via the proven and scalable Oracle Health Sciences Cloud, enables health sciences organizations to optimize their safety investment accelerating implementation while reducing IT management resource requirements and infrastructure costs and gaining more predictable IT spend.
The cloud-based, end-to-end solution enables deployment flexibility without lock in. In addition, world-class security, disaster recovery and best practice governance and compliance reduce risk and standardized processes and tools, along with global scale and deep system expertise at every technology layer, ensure enterprise-grade performance.
“Oracle Argus Cloud Service delivers extended value to health sciences organizations with the addition of Oracle Argus Japan, Oracle Argus Analytics and Oracle Argus Insight. Trial sponsors and contract research organizations can manage their end-to-end safety and pharmacovigilance programs with a leading solution suite while benefitting from a cloud-based delivery model that helps accelerate time to value, reduce risk, cut total cost of IT ownership and that provides unprecedented performance and scalability,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.
Oracle (oracle.com) engineers hardware and software to work together in the cloud and in your data center.
About Oracle in Industries
Oracle industry solutions leverage the company’s best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.
About Oracle Health Sciences
At Oracle, we believe that a more predictive, preventive, personalized and participatory system will help improve human health. We can help accelerate this journey to personalized medicine through technology, data and insights. Oracle’s solutions support industry initiatives to improve care quality and outcomes, reduce costs, and speed time to market for new treatments, therapies and devices.
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
Contact: Mary Tobin, O’Keeffe & Company
P: +1 503-658-7396 - E: mtobin[.]okco.com.